RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

Details for Australian Patent Application No. 2006330590 (hide)

Owner Alcon Research, Ltd.

Inventors Chatterton, Jon E.; Bingaman, David P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006330590

PCT Pub. Number WO2007/076351

Priority 60/754,956 29.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/076351 Priority application(s): WO2007/076351

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330593-Stable protein formulations

2006330587-Azaindole inhibitors of aurora kinases